Skip to main content

and
  1. No Access

    Article

    A prognostic score model for predicting the survival benefits of patients undergoing sorafenib plus transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion

    The survival benefits and which patients with advanced hepatocellular carcinoma (HCC) would benefit from sorafenib plus transarterial chemoembolization (TACE) therapy remain controversial. We aimed to develop ...

    Ji-Rong Li, Min-Jiang Wu, Tan Wang, Min Tian, Guang Zhou in Abdominal Radiology (2021)